No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk

A.M. Spoelstra-de Man, T. Teerlink, C.B. Brouwer, J.A. Rauwerda, C.D. Stehouwer, Y.M. Smulders

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Abstract

OBJECTIVE: Asymmetric dimethylarginine (ADMA) is a recently identified potent cardiovascular risk factor. ADMA levels are increased in hyperhomocysteinaemia and the metabolism of ADMA is linked with that of homocysteine in several ways. Treatment with B vitamins effectively reduces homocysteine levels, but studies investigating the effect on ADMA levels are scarce and show conflicting results. In this study we evaluated the effect of treatment with B vitamins on ADMA levels in two high cardiovascular risk populations. METHODS: In study I, 110 siblings of patients with clinical atherosclerotic disease and postmethionine hyperhomocysteinaemia were treated with 5 mg of folic acid and 250 mg of pyridoxine or placebo, and were analysed after 1 year. In study II, 41 patients with type 2 diabetes and mild hyperhomocysteinaemia were analysed after 6 months treatment with 5 mg of folic acid or placebo. RESULTS: A correlation between baseline homocysteine and ADMA levels was found, which was partly due to confounding by renal function. Homocysteine levels decreased by 43% in study I and by 28% in study II. In both studies, treatment with B vitamins had no effect at all on ADMA, arginine/ADMA ratio and SDMA levels. This result was confirmed in multiple linear regression analyses with adjustment for baseline values and gender. CONCLUSIONS: Our studies indicate that B vitamins, despite causing a substantial reduction in plasma homocysteine levels, have no beneficial effect on ADMA levels.
Original languageEnglish
Pages (from-to)495-501
JournalClinical Endocrinology
Volume64
Issue number5
DOIs
Publication statusPublished - 1 Jan 2006

Cite this

Spoelstra-de Man, A. M., Teerlink, T., Brouwer, C. B., Rauwerda, J. A., Stehouwer, C. D., & Smulders, Y. M. (2006). No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk. Clinical Endocrinology, 64(5), 495-501. https://doi.org/10.1111/j.1365-2265.2006.02497.x